BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

488 related articles for article (PubMed ID: 28618099)

  • 1. EPEC effector EspF promotes Crumbs3 endocytosis and disrupts epithelial cell polarity.
    Tapia R; Kralicek SE; Hecht GA
    Cell Microbiol; 2017 Nov; 19(11):. PubMed ID: 28618099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enteropathogenic
    Tapia R; Kralicek SE; Hecht GA
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31947656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disruption of cell polarity by enteropathogenic Escherichia coli enables basolateral membrane proteins to migrate apically and to potentiate physiological consequences.
    Muza-Moons MM; Koutsouris A; Hecht G
    Infect Immun; 2003 Dec; 71(12):7069-78. PubMed ID: 14638797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. E. coli secreted protein F promotes EPEC invasion of intestinal epithelial cells via an SNX9-dependent mechanism.
    Weflen AW; Alto NM; Viswanathan VK; Hecht G
    Cell Microbiol; 2010 Jul; 12(7):919-29. PubMed ID: 20088948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The basolateral vesicle sorting machinery and basolateral proteins are recruited to the site of enteropathogenic E. coli microcolony growth at the apical membrane.
    Pedersen GA; Jensen HH; Schelde AB; Toft C; Pedersen HN; Ulrichsen M; Login FH; Amieva MR; Nejsum LN
    PLoS One; 2017; 12(6):e0179122. PubMed ID: 28636623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tight Junction Disruption Induced by Type 3 Secretion System Effectors Injected by Enteropathogenic and Enterohemorrhagic Escherichia coli.
    Ugalde-Silva P; Gonzalez-Lugo O; Navarro-Garcia F
    Front Cell Infect Microbiol; 2016; 6():87. PubMed ID: 27606286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enteropathogenic E. coli disrupts tight junction barrier function and structure in vivo.
    Shifflett DE; Clayburgh DR; Koutsouris A; Turner JR; Hecht GA
    Lab Invest; 2005 Oct; 85(10):1308-24. PubMed ID: 16127426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enteropathogenic E. coli effectors EspF and Map independently disrupt tight junctions through distinct mechanisms involving transcriptional and post-transcriptional regulation.
    Singh AP; Sharma S; Pagarware K; Siraji RA; Ansari I; Mandal A; Walling P; Aijaz S
    Sci Rep; 2018 Feb; 8(1):3719. PubMed ID: 29487356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coordinated transient interaction of ZO-1 and afadin is required for pedestal maturation induced by EspF from enteropathogenic Escherichia coli.
    Ugalde-Silva P; Navarro-Garcia F
    Microbiologyopen; 2019 Dec; 8(12):e931. PubMed ID: 31568664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tight junctions and enteropathogenic E. coli.
    Weflen AW; Alto NM; Hecht GA
    Ann N Y Acad Sci; 2009 May; 1165():169-74. PubMed ID: 19538303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enteropathogenic Escherichia coli remodels host endosomes to promote endocytic turnover and breakdown of surface polarity.
    Kassa EG; Zlotkin-Rivkin E; Friedman G; Ramachandran RP; Melamed-Book N; Weiss AM; Belenky M; Reichmann D; Breuer W; Pal RR; Rosenshine I; Lapierre LA; Goldenring JR; Aroeti B
    PLoS Pathog; 2019 Jun; 15(6):e1007851. PubMed ID: 31242273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enteropathogenic E. coli-induced barrier function alteration is not a consequence of host cell apoptosis.
    Viswanathan VK; Weflen A; Koutsouris A; Roxas JL; Hecht G
    Am J Physiol Gastrointest Liver Physiol; 2008 May; 294(5):G1165-70. PubMed ID: 18356531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The type III effector EspF coordinates membrane trafficking by the spatiotemporal activation of two eukaryotic signaling pathways.
    Alto NM; Weflen AW; Rardin MJ; Yarar D; Lazar CS; Tonikian R; Koller A; Taylor SS; Boone C; Sidhu SS; Schmid SL; Hecht GA; Dixon JE
    J Cell Biol; 2007 Sep; 178(7):1265-78. PubMed ID: 17893247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enteropathogenic Escherichia coli dynamically regulates EGFR signaling in intestinal epithelial cells.
    Roxas JL; Ryan K; Vedantam G; Viswanathan VK
    Am J Physiol Gastrointest Liver Physiol; 2014 Aug; 307(3):G374-80. PubMed ID: 24904077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of a MDCK cell line with constitutive expression of the Enteropathogenic E. coli effector protein Map as an in vitro model of pathogenesis.
    Singh AP; Aijaz S
    Bioengineered; 2015; 6(6):335-41. PubMed ID: 26430918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRB3 binds directly to Par6 and regulates the morphogenesis of the tight junctions in mammalian epithelial cells.
    Lemmers C; Michel D; Lane-Guermonprez L; Delgrossi MH; Médina E; Arsanto JP; Le Bivic A
    Mol Biol Cell; 2004 Mar; 15(3):1324-33. PubMed ID: 14718572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crumbs3 is essential for proper epithelial development and viability.
    Whiteman EL; Fan S; Harder JL; Walton KD; Liu CJ; Soofi A; Fogg VC; Hershenson MB; Dressler GR; Deutsch GH; Gumucio DL; Margolis B
    Mol Cell Biol; 2014 Jan; 34(1):43-56. PubMed ID: 24164893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tricellular Tight Junction Protein Tricellulin Is Targeted by the Enteropathogenic Escherichia coli Effector EspG1, Leading to Epithelial Barrier Disruption.
    Morampudi V; Graef FA; Stahl M; Dalwadi U; Conlin VS; Huang T; Vallance BA; Yu HB; Jacobson K
    Infect Immun; 2017 Jan; 85(1):. PubMed ID: 27795363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The bacterial virulence factor NleA is required for the disruption of intestinal tight junctions by enteropathogenic Escherichia coli.
    Thanabalasuriar A; Koutsouris A; Weflen A; Mimee M; Hecht G; Gruenheid S
    Cell Microbiol; 2010 Jan; 12(1):31-41. PubMed ID: 19712078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attaching-and-Effacing Pathogens Exploit Junction Regulatory Activities of N-WASP and SNX9 to Disrupt the Intestinal Barrier.
    Garber JJ; Mallick EM; Scanlon KM; Turner JR; Donnenberg MS; Leong JM; Snapper SB
    Cell Mol Gastroenterol Hepatol; 2018 Mar; 5(3):273-288. PubMed ID: 29675452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.